| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 408,358 | 413,748 | 388,518 | 432,388 | | Cost of Revenue | 278,879 | 280,639 | 258,934 | 287,260 | | | Gross Profit | 129,479 | 133,109 | 129,584 | 145,128 | | | Operating Expenses | | Research Development | 31,077 | 30,809 | 31,158 | 28,416 | | Selling General and Administrative | 64,275 | 66,392 | 65,999 | 68,438 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 25,121 | 24,189 | 23,478 | 27,250 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,006 | 11,719 | 8,949 | 21,024 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,039) | (2,396) | (11,839) | 78 | | Earnings Before Interest And Taxes | 1,967 | 9,323 | (2,890) | 21,102 | | Interest Expense | 20,075 | 16,399 | 16,845 | 15,368 | | Income Before Tax | (18,108) | (7,076) | (19,735) | 5,734 | | Income Tax Expense | (15,146) | (22,365) | (6) | 1,428 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,762) | 15,289 | (19,729) | 4,306 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,962) | 15,289 | (19,729) | 4,306 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,962) | $15,289 | ($19,729) | $4,306 |
|
0.02% Nasdaq 
0.33%
Income Statement
